Quality control and non-clinical testing of iPSC- and ESC-derived medicinal products: A systematic review
Open Access
- 24 September 2026
- journal article
- review article
- Published by Elsevier in Stem Cell Reports
- Vol. 21 (10) , 103084
Abstract
No abstract availableKeywords
Funding Information
- Leids Universitair Medisch Centrum
This publication has 69 references indexed in Scilit:
- From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell TherapyAdvanced Science, 2025
- A spatiotemporal and machine-learning platform facilitates the manufacturing of hPSC-derived esophageal mucosaDevelopmental Cell, 2025
- Biomechanical Characterization of Retinal Pigment Epitheliums Derived from hPSCs Using Atomic Force MicroscopyStem Cell Reviews and Reports, 2024
- Alternative In Vivo Models to Study Teratoma2022
- Intracerebroventricular transplantation of human iPSC-derived neural stem cells (hiPSC-NSCs) into neonatal mice2022
- Sensitive detection of electrophysiology and dopamine vesicular exocytosis of hESC-derived dopaminergic neurons using multifunctional microelectrode arrayBiosensors and Bioelectronics, 2022
- Derivation and Characterization of Mesenchymal Stem Cells from iPS Cells2020
- Tumorigenicity assessment of cell therapy products: The need for global consensus and points to considerCytotherapy, 2019
- Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord InjuryStem Cells Translational Medicine, 2017
- Application of the Isoenzyme Profile in the Development of Cell-Based DevicesActa Biotechnologica, 2001